PTSD
Pipeline by Development Stage
Competitive Landscape
24 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 40 trials with date data
Clinical Trials (40)
Total enrollment: 3,327 patients across 40 trials
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD
A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome
Safety and Efficacy Study of TNX-102 SL in Participants With PTSD
Acceptability and Feasibility of Apollo in Veterans With a History of PTSD
Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions
Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions
7-Keto DHEA for the Treatment of PTSD
Ganaxolone in Posttraumatic Stress Disorder (PTSD)
Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder
First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)
Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)
Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans
Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers
Study of SRX246 Capsules in Healthy Adult Volunteers
Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD)
Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder
Clinical Observation and Risk Factor Analysis of the Incidence of Postoperative PTSD in Children
Project Safe Guard-Trauma
Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder
Biomarkers in the Retina for Prognosticating Mental Health Treatments
Program for Alleviating and Reducing Trauma, Stress, and Substance Use
Primary Care Intervention for PTSD in Ethiopia
Treatment for Antepartum Posttraumatic Stress Disorder/PTSD Study
I MOVE!+UP: Piloting an Integrated Weight Management Program for Veterans With PTSD
Electrical Vestibular Nerve Stimulation (VeNS) as a Method of Sleep Management in People With PTSD
RRT for PTSD Symptoms in Survivors of Sexual Violence
Implementing PTSD Treatment in FQHCs for Michigan Medicaid Enrollees
Synchronized Transcranial Magnetic Stimulation for PTSD
Big Mind for Veterans With PTSD
Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
UCLA Couples Counseling for Combat Veterans
Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans
Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder
Related Jobs
National Sales Director (East)
Associate Director, Commercial Forecasting
Regional Sales Director (Mid-Atlantic)
Regional Sales Director (Texas)
Regional Sales Director (Southern California)
Regional Sales Director (Pacific Northwest)
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.